What trends in CC's earnings suggest for Q1 next year?

Chemours (CC) suggests a mixed outlook for Q1 2025 based on current earnings trends and analyst expectations:

1. **Expected Earnings Decline**: CC is anticipated to deliver a year-over-year decline in earnings on lower revenues for Q1 2025, with estimated EPS of $0.19 and revenue of $1.38 billion. This represents a decrease from the previous year's EPS of $0.31 and revenue of $1.36 billion for the same quarter.

2. **Historical Performance**: CC has a track record of surpassing consensus EPS estimates three times over the last four quarters, but has not consistently exceeded revenue estimates. For Q1 2025, the company is expected to miss revenue expectations by 0.06%, which could indicate potential challenges in achieving revenue growth.
3. **Recent Performance**: CC's stock has underperformed the market, losing about 0.4% since the beginning of the year compared to the S&P 500's gain of 4%. This suggests that the company may be facing broader market challenges that could impact its earnings in the upcoming quarter.
4. **Analyst Sentiment**: The consensus EPS estimate for Q1 2025 has been revised 8.93% lower over the last 30 days, reflecting a more cautious outlook from analysts. This revision trend suggests that analysts are anticipating potential headwinds for CC in the coming quarter.

In conclusion, while CC has a history of beating earnings expectations, the anticipated decline in earnings and the revision in analyst estimates suggest a cautious outlook for Q1 2025. The company will need to navigate potential challenges and manage market conditions effectively to achieve better-than-expected results.